SB
Stephen R Brady
President and CEO

Stephen R Brady insider trades: Tempest Therapeutics (TPST) stock buys and sales

President and CEO, Tempest Therapeutics Last trade Jul 3, 2024 21 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
5
Open-market trades
since 2016
3
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Stephen reports to the SEC

Open-market buys and sales

5 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 3, 2024TPST↑ Buy$74K
Jan 7, 2019IMDZ↓ Sell$9K
Jan 5, 2018IMDZ↓ Sell10b5-1$14K
Jan 4, 2017IMDZ↓ Sell10b5-1$9K
Jul 15, 2016IMDZ↑ Buy$10K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other TPST insiders

Open-market trades in the last 12 months

About Stephen R Brady's insider trades

Stephen R Brady is President and CEO at Tempest Therapeutics (TPST). Since Jul 15, 2016, Stephen has reported 2 open-market purchases worth $84K and 3 sales worth $31K on SEC Form 4. There have been no open-market trades in the last 12 months.

2 sales (72% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (18 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TPST insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.